Literature DB >> 12444599

New model of glutathione deficit during development: Effect on lipid peroxidation in the rat brain.

Michaël Rougemont1, Kim Quang Do, Vincent Castagné.   

Abstract

Glutathione is a major regulator of the redox equilibrium, so its deficit weakens tissue resistance to oxidants. The nervous system is particularly susceptible to oxidative insults and is therefore very dependent on its glutathione content, especially during development, when brain metabolism and growth are maximal. In addition, various pathologies affecting the nervous system involve oxidative stress, possibly associated with a diminution of glutathione concentrations. To study the involvement of glutathione in brain redox homeostasis, we set up an experimental model of chronic glutathione deficit. Developing rats were treated daily with L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of glutathione synthesis, and their brain levels of glutathione and lipid peroxidation products (TBARS) were measured. BSO induced a 40-50% glutathione deficit in the cortex, diencephalon, and pons/medulla. Despite the glutathione deficit induced by BSO, we did not observe any signs of oxidative stress. Because it is known that rats compensate for a glutathione deficit by enhancing their synthesis and tissue levels of ascorbic acid (AA), we performed the same experiment in osteogenic-disorder Shionogi (ODS) rats, a mutant strain that cannot synthetize AA. Although BSO induced a glutathione deficit of comparable intensity in the two strains of rats, it elevated TBARS levels in the diencephalon and pons/medulla only in ODS and not in nonmutant rats. These results suggest that ODS rats, which closely mimic the human redox regulation, will allow study of the long-term consequences of chronic glutathione deficit observed in various clinical situations. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444599     DOI: 10.1002/jnr.10439

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Nitroso-redox status and vascular function in marginal and severe ascorbate deficiency.

Authors:  Maria-Francisca Garcia-Saura; Fumito Saijo; Nathan S Bryan; Selena Bauer; Juan Rodriguez; Martin Feelisch
Journal:  Antioxid Redox Signal       Date:  2012-03-08       Impact factor: 8.401

Review 2.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

3.  The Effect of Glutathione Deficit During Early Postnatal Brain Development on the Prepulse Inhibition and Monoamine Levels in Brain Structures of Adult Sprague-Dawley Rats.

Authors:  Zofia Rogóż; Marta A Lech; Katarzyna Chamera; Agnieszka Wąsik
Journal:  Neurotox Res       Date:  2022-04-07       Impact factor: 3.911

4.  Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial.

Authors:  Cristian Carmeli; Maria G Knyazeva; Michel Cuénod; Kim Q Do
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 5.  Neuroprotection in Schizophrenia and Its Therapeutic Implications.

Authors:  Yong-Ku Kim; Kyoung-Sae Na
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

6.  Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats.

Authors:  Magdalena Górny; Agnieszka Wnuk; Adrianna Kamińska; Kinga Kamińska; Grażyna Chwatko; Anna Bilska-Wilkosz; Małgorzata Iciek; Małgorzata Kajta; Zofia Rogóż; Elżbieta Lorenc-Koci
Journal:  Molecules       Date:  2019-11-22       Impact factor: 4.411

7.  Impact of repeated co-treatment with escitalopram and aripiprazole on the schizophrenia-like behaviors and BDNF mRNA expression in the adult Sprague-Dawley rats exposed to glutathione deficit during early postnatal development of the brain.

Authors:  Marta A Lech; Kinga Kamińska; Monika Leśkiewicz; Elżbieta Lorenc-Koci; Zofia Rogóż
Journal:  Pharmacol Rep       Date:  2021-08-16       Impact factor: 3.024

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.